Todisco Joseph 4
4 · CorMedix Inc. · Filed Sep 12, 2025
Insider Transaction Report
Form 4
CorMedix Inc.CRMD
Todisco Joseph
DirectorChief Executive Officer
Transactions
- Exercise/Conversion
Common Stock
2025-09-12$3.47/sh+50,000$173,500→ 559,496 total - Exercise/Conversion
Stock Option (Right to Buy Common Stock)
2025-09-12−50,000→ 216,667 totalExercise: $3.47Exp: 2034-01-11→ Common Stock (50,000 underlying) - Sale
Common Stock
2025-09-12$13.00/sh−50,000$650,000→ 509,496 total
Footnotes (2)
- [F1]This transaction was executed in multiple trades at prices ranging from $12.82 to $13.27. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
- [F2]These options were granted on 01/12/2024. These options vest 1/4 on the date of grant, and, subject to continued employment, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.